Burcu Duyur Çakıt

Burcu Duyur Çakıt

Auto-generated profile, based on publicly available information

Burcu Duyur Çakıt

11 Department of Physical Medicine and Rehabilitation, University of Health Sciences, Ankara Training and Research Hospital, Ankara, Türkiye

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2021 in Turkish Journal of Physical Medicine and Rehabilitation
Verified
Journal Article
Open access
YAYeşim Kurtaiş Aytür
Yeşim Kurtaiş Aytür
BKBelma Füsun Köseoglu
Belma Füsun Köseoglu
Ozden Ozyemisci TaskiranOzden Ozyemisci Taskiran
Ozden Ozyemisci Taskiran
NGNilüfer Kutay Ordu Gökkaya
Nilüfer Kutay Ordu Gökkaya
SDSibel Ünsal Delialioğlu
Sibel Ünsal Delialioğlu
CTCanan Tıkız
Canan Tıkız
Coronavirus disease 2019 (COVID-19) is a contagious infection disease, which may cause respiratory, physical, psychological, and generalized systemic dysfunction. The severity of disease ranges from an asymptomatic infection or mild illness to mild or severe pneumonia with respiratory failure and/or death. COVID-19 dramatically affects the pulmonary system. This clinical practice guideline includes pulmonary rehabilitation (PR) recommendations for adult COVID-19 patients and has been developed in the light of the guidelines on the diagnosis and treatment of COVID-19 provided by the World Health Organization and Republic of Turkey, Ministry of Health, recently published scientific literature, and PR recommendations for COVID-19 regarding basic principles of PR. This national guideline provides suggestions regarding the PR methods during the clinical stages of COVID-19 and post-COVID-19 with its possible benefits, contraindications, and disadvantages.

15 January 2024 in Turkish Journal of Physical Medicine and Rehabilitation
Verified
Journal Article
Open access
FAFikriye Figen Ayhan
Fikriye Figen Ayhan
AÇAyşegül Demirci Çoban
Ayşegül Demirci Çoban
AKAyça Utkan Karasu
Ayça Utkan Karasu
BKBelgin Karaoğlan
Belgin Karaoğlan
EÇEce Çınar
Ece Çınar
MDMeltem Dalyan
Meltem Dalyan
Objectives: This study aimed to evaluate the effects of the combined hydrolyzed type 2 collagen, methylsulfonylmethane (MSM), glucosamine sulfate (GS), and chondroitin sulfate (CS) supplement on knee pain intensity in patients with knee osteoarthritis (OA). Patients and methods: This multicenter, observational, noninterventional study included 98 patients (78 females, 20 males; mean age: 52.8±6.5 years; range, 40 to 64 years) who had Grade 1-3 knee OA between May 2022 and November 2022. The patients were prescribed the combination of hydrolyzed type 2 collagen, MSM, GS, and CS as a supplement for knee OA. The sachet form of the combined supplement containing 1250 mg hydrolyzed type 2 collagen, 750 mg MSM, 750 mg GS, and 400 mg CS was used once daily for two consecutive months. Patients were evaluated according to the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Visual Analog Scale (VAS)-pain, and Health Assessment Questionnaire (HAQ). Patients were scheduled to visit for follow-up four weeks (Visit 2) and eight weeks (Visit 3) after Visit 1 (baseline; day 0 of the study). Results: For the VAS-pain, WOMAC, WOMAC-subscale, and HAQ scores, the differences in improvement between the three visits were significant (p<0.001 for all). The patient compliance with the supplement was a median of 96.77%, both for Visit 2 and Visit 3. Conclusion: The combination of hydrolyzed type 2 collagen, MSM, GS, and CS for eight weeks in knee OA was considered an effective and safe nutritional supplement.

1 March 2021 in European Journal of Cancer Care
Verified
Journal Article
Closed access
PDF file
BÇBurcu Duyur Çakıt
Burcu Duyur Çakıt
FAF. Figen Ayhan
F. Figen Ayhan
SASefa Gümrük aslan
Sefa Gümrük aslan
HGHakan Genç
Hakan Genç
Objective To determine the role of ultrasonography in the follow-up of effectiveness of complex decongestive therapy (CDT) in different subgroups of patients with breast cancer-related lymphoedema (BCRL). Methods Forty-seven patients with unilateral upper BCRL were enrolled in the study. The patient group was divided into two subgroups according to body mass index (BMI) as obese and non-obese and three subgroups according to International Society of Lymphology staging. All patients underwent CDT, the circumference measurements and ultrasonographic soft tissue thicknesses evaluations were performed at two anatomic sites, and upper extremity limb volumes were calculated using the truncated cone formula before and after CDT. Results There were significant decreases in both circumferential measurements and ultrasonographic soft tissue thicknesses in non-obese patients and stage 2 lymphoedema patients after 15 sessions of CDT. The ultrasonographic soft tissue thickness values were correlated with the upper arm and forearm circumference values before (r = 0.491, p < .001, r = 0.841, p < .001, respectively) and after (r = 0.535, p < .001, r = 0.714, p < .001, respectively) CDT. Conclusions Ultrasonography presents as a reliable method to measure the soft tissue thickness and treatment efficacy after CDT in only non-obese and stage 2 patients with BCRL.

10 November 2018 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
SVSecil Pervane Vural
Secil Pervane Vural
FAF. Figen Ayhan
F. Figen Ayhan
BCBurcu Duyur Cakit
Burcu Duyur Cakit
ASAtilla Soran
Atilla Soran

28 June 2023 in Journal of Medicine and Palliative Care
Verified
Journal Article
Open access
PDF file
MÇMehmet Onat Çakit
Mehmet Onat Çakit
BABusem Atar
Busem Atar
SASatı Zülal AYAZ
Satı Zülal AYAZ
ÖÇÖmer Faruk Çeli̇k
Ömer Faruk Çeli̇k
AGAyşe Güliz GÜRDAL
Ayşe Güliz GÜRDAL
BÇBurcu Duyur Çakit
Burcu Duyur Çakit
Aims: Both Fibromyalgia (FMS) and lipedema are characterized by pain in the soft tissue, and they have clinically similar aspects. The Aims of this study were to determine how many of the patients with lipedema met the diagnostic criteria for FMS, the effect of the comorbidity of lipedema and FMS on pain and quality of life, and their relationship with extremity volumes, ultrasonographically measured soft tissue thickness and lipedema disease severity. Methods: 53 women with lipedema and 32 patients with FMS without lipedema were included in the study. Symptom severity scale, widespread pain index, and FMS severity scale were calculated for the diagnosis of FMS. Pain intensity was determined by visual analog scale (VAS). The frequency of fibromyalgia was determined in the lipedema group. Lower extremity volumes of both groups were calculated by circumferential measurements and thigh and pretibial soft tissue thicknesses were measured ultrasonographically. Short form-36 quality of life scale was applied to both groups. Results: The mean age of the 53 females with lipedema was 52±11.8 years, and for the 32 females with FMS it was 51.9±10.1 years (p>0.05). The extremity volumes and soft tissue thicknesses were higher in lipedema group than FMS group p

1 January 2022 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
PDF file
PBPınar Borman
Pınar Borman
ABAyşegül Balcan
Ayşegül Balcan
SESi̇bEl Eyi̇gÖr
Si̇bEl Eyi̇gÖr
ECEvri̇m Coşkun
Evri̇m Coşkun
FAFi̇kRi̇yE Fi̇gEn Ayhan
Fi̇kRi̇yE Fi̇gEn Ayhan
SDSevil Ceyhan Doğan
Sevil Ceyhan Doğan
Background/aim: Reducing lymphedema-associated burden and disability in the pediatric setting requires improved awareness and understanding clinical properties of the lymphedema. The aim of this study was to evaluate the clinical and demographic characteristics of patients with pediatric lymphedema presented to different lymphedema centers in Turkey. Materials and methods: The socio-demographic and clinical characteristics of the children including age, gender, presence of genetic syndromes, duration of edema, site and stage of lymphedema and the received therapies were determined. Parental and children education on self-management techniques were recorded. Results: A total of 122 children (female: 66, male: 56) with a mean age of 120.7 ± 71.2 months were included from 7 centers. Of them; 92% had primary, 8% had secondary lymphedema mostly due to infection and trauma. Lymphedema was part of a syndrome in 18% of the children. The most common site of involvement was the lower extremity, followed by upper extremity and genital involvement. Lymphedema was complicated in 17 % of children, mainly with a clinical picture of cellulitis, infection, and pain. The median duration of lymphedema was 41 (5-216) months. Although most of the children had stage 2 lymphedema, only 40% of them received treatment. The most commonly received treatment was compression therapy. No family or child was educated for self- care management before. Conclusion: In conclusion, pediatric lymphedema has a comparable gender distribution and usually involves the lower extremities. Although most of the children had advanced disease, more than half of the patients did not receive any treatment indicating the unmet need for management of lymphedema. The education of patients and/or children about self-management methods were lacking. We suggest educational activities for both families of children with lymphedema and health care providers, in order to facilitate early reference to lymphedema units and to receive prompt preventive and therapeutic approaches for this suffering condition.